Related Experiment Videos
Intraoperative autotransfusion. Experience in 725 consecutive cases.
Annals of Surgery
|May 1, 1983
Summary
Autologous intraoperative transfusion using the Cell Saver significantly reduces bank blood use in surgeries, especially cardiovascular procedures. This safe and efficient method offers numerous benefits, including preventing transfusion reactions and diseases.
Area of Science:
- Transfusion Medicine
- Surgical Techniques
- Blood Conservation
Background:
- Autologous intraoperative transfusion is an alternative to homologous blood transfusions.
- The Haemonetics Cell Saver is a device used for collecting and processing blood during surgery.
Purpose of the Study:
- To evaluate the efficacy and safety of autologous intraoperative transfusion using the Haemonetics Cell Saver.
- To assess the impact of Cell Saver use on homologous blood utilization in various surgical procedures.
Main Methods:
- A retrospective analysis of 725 patients undergoing autologous intraoperative transfusion with the Cell Saver.
- Comparison of homologous blood usage in 100 cardiac surgery patients before and after Cell Saver implementation.
Main Results:
- Average yield of 573 cc washed red blood cells per case.
- Significant reduction in bank blood use during cardiac surgery (0.75 units with Cell Saver vs. 1.97 units without, p < 0.0001).
- Overall mortality rate of 2.8%, with no deaths or morbidity attributed to autologous transfusion.
Conclusions:
- Autologous intraoperative transfusion with the Cell Saver is safe and effective in reducing homologous blood requirements.
- Benefits include prevention of alloimmunization, avoidance of transfusion-transmitted diseases, and cost-effectiveness in cases of significant blood loss.
- This technique proved life-saving in some instances and conserves blood bank resources.